Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection
Tropical Medicine and Infectious Disease · 28.01.2023 · 8 (2) · 89
DOI: 10.3390/tropicalmed8020089 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Tropical Medicine and Infectious Disease, online erschienen am 28.01.2023. Verfasst von Kai Ling Chin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu 88400, Malaysia. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 266 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Malaysia Ministry of Education, Fundamental Research Grant Scheme for Research Acculturation of Early Career Researchers, Malaysia Ministry of Education and UMSGreat.
Abstract (Originalsprache)
Globally, it is estimated that one-quarter of the world’s population is latently infected with Mycobacterium tuberculosis (Mtb), also known as latent tuberculosis infection (LTBI). Recently, this condition has been referred to as tuberculosis infection (TBI), considering the dynamic spectrum of the infection, as 5–10% of the latently infected population will develop active TB (ATB). The chances of TBI development increase due to close contact with index TB patients. The emergence of multidrug-resistant TB (MDR-TB) and the risk of development of latent MDR-TB has further complicated the situation. Detection of TBI is challenging as the infected individual does not present symptoms. Currently, there is no gold standard for TBI diagnosis, and the only screening tests are tuberculin skin test (TST) and interferon gamma release assays (IGRAs). However, these tests have several limitations, including the inability to differentiate between ATB and TBI, false-positive results in BCG-vaccinated individuals (only for TST), false-negative results in children, elderly, and immunocompromised patients, and the inability to predict the progression to ATB, among others. Thus, new host markers and Mtb-specific antigens are being tested to develop new diagnostic methods. Besides screening, TBI therapy is a key intervention for TB control. However, the long-course treatment and associated side effects result in non-adherence to the treatment. Additionally, the latent MDR strains are not susceptible to the current TBI treatments, which add an additional challenge. This review discusses the current situation of TBI, as well as the challenges and efforts involved in its control.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu 88400, Malaysia.
- Borneo Medical and Health Research Centre, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu 88400, Malaysia.
- Tuberculosis Unit, Infectious Diseases and Internal Medicine Department, Complexo Hospitalario Universitario de Pontevedra, 36071 Pontevedra, Spain.
- Immunology Research Group, Galicia Sur Health Research Institute (IIS-GS), 36312 Vigo, Spain.
- School of Health Sciences, Universiti Sains Malaysia, Health Campus, Kubang Kerian 16150, Malaysia.
ORCID-Profile: Kai Ling Chin, Luis Anibarro
Förderung
- Malaysia Ministry of Education
- Fundamental Research Grant Scheme for Research Acculturation of Early Career Researchers
- Malaysia Ministry of Education and UMSGreat
Zitieren
APA
Chin, K. L., Anibarro, L., Sarmiento, M. E., & Acosta, A. (2023). Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection. Tropical Medicine and Infectious Disease, 8(2), 89. https://doi.org/10.3390/tropicalmed8020089
Vancouver
Chin KL, Anibarro L, Sarmiento ME, Acosta A. Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection. Tropical Medicine and Infectious Disease. 2023;8(2):89. doi:10.3390/tropicalmed8020089
BibTeX
@article{Chin2023,
author = {Chin, Kai Ling and Anibarro, Luis and Sarmiento, Maria E and Acosta, Armando},
title = {Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection},
journal = {Tropical Medicine and Infectious Disease},
year = {2023},
volume = {8},
number = {2},
pages = {89},
doi = {10.3390/tropicalmed8020089}
}
EUVIMED